New York, NY
On April 25, Erin Austin will be speaking at ACI's Annual Paragraph IV Disputes conference in New York on the panel "AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape." The panel will discuss the impact of AI on life sciences IP and Hatch-Waxman litigation and how AI is revolutionizing drug discovery and development. They will also speak to the new challenges and opportunities for IP protection and litigation under Hatch-Waxman, and predicting AI's role in patentability matters and data protection and its influence on future litigation.
To register, click here.